Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Preclinical Research

Bear-faced lie? Amgen retracts diabetes-obesity paper due to data manipulation

02-Sep-2015 - Amgen has retracted a study showing how grizzly bears could hold the key to understanding diabetes after one of the authors was found to have manipulated data.

WuXi enters strategic lab testing partnership with HK-based firm

28-Aug-2015 - WuXi PharmaTech has signed a strategic partnership deal to provide exclusive laboratory testing services to Hong Kong-headquartered Lee’s Pharmaceutical.

Anti-Nazi laws and a lack of alternatives: Factors slowing adoption of non-animal models

24-Aug-2015 - Laws prompted by Nazi atrocities combined with efficacy concerns about the few available alternatives mean the drug industry still favours animal models for preclinical research according to experts.

Preclinical firms donate mouse models for rare disease study

24-Aug-2015 - Animal model maker Taconic Biosciences has announced it will use CRISPR-Cas9 technology to breed custom mice to study Vici Syndrome.

$47m innovation facility built in Nottingham, UK

21-Aug-2015 - The UK’s BioCity in Nottingham is adding a £30m ($47m) facility to house life science start-ups including CROs. The site will also become a hunting ground for a soon-to-launch venture...

Takeda invests in microdose tech collaborator Presage Biosciences

20-Aug-2015 - Takeda has invested in Presage Biosciences whose tech platform is designed to let pharmas test multiple cancer drug combinations in a single trial.

Concept Life Sciences buys UK toxicology biz

18-Aug-2015 - British CRO Concept Life Sciences has bought toxicology business CXR Biosciences, its fourth acquisition since it formed in July 2014.

News in brief

BASi sees Q3 profit rise due to early preclinical project terminations

17-Aug-2015 - One of the smaller contract research providers -- Bioanalytical Systems (BASi) – has reported modest revenue and profit gains for Q3. 

Charles River plans cautious approach to re-opening of Shrewsbury preclinical site

14-Aug-2015 - After months of speculation , Charles River Laboratories has decided to move forward with the re-opening of its early-stage research site in Shrewsbury, Massachusetts sometime in the first quarter of 2016.

Probe opprobrium: Scientists hope reagent database will improve drug research

22-Jul-2015 - Poor biochemical probes mean some drug discovery research is wasted according to academics behind a website intended to help biopharmaceutical developers choose the best reagents.

Independent lab network enters CRO market with acquisition of ABC Laboratories

22-Jul-2015 - EAG (Evans Analytical Group), an independent laboratory network, has acquired Missouri-based Analytical Bio-Chemistry Laboratories (ABC Labs). Financial terms of the transaction were not disclosed. 

Stem Cell Theranostics secures "freedom to operate" in IP deal with GE Healthcare

21-Jul-2015 - Stem Cell Theranostics has secured rights to the technology it uses to make cellular heart disease models for drug development through a deal with GE Healthcare.

Aptuit expands to bring on later-stage capabilities following client demand

14-Jul-2015 - CDMO (contract development and manufacturing organization) Aptuit is investing in additional scale and capabilities at its Italian site to augment its 1600L scale API capability and to add a commercial...

Heating issues caused death of 39 Guinea pigs at JHP Pharma facility

10-Jul-2015 - Par Pharmaceuticals says it has addressed its temperature-control system at a Michigan facility after overheating caused the death of 39 guinea pigs.

News in brief

Parexel expands model-based drug development services

10-Jul-2015 - Massachusetts-based CRO Parexel has expanded its services and capabilities in model-based drug development (MBDD) via its Quantitative Clinical Development (QCD) unit.  

News in brief

SCRS makes Covance its fifth CRO partner

26-Jun-2015 - The Society for Clinical Research Sites (SCRS), a trade organization representing the interests of clinical research sites, has announced a two-year partnership with LabCorp’s Covance. 

News in brief

Huntingdon Life Sciences unveils new name post-Harlan integration

25-Jun-2015 - Preclinical CRO Huntingdon Life Sciences has announced a new name, which it changed to mark the integration of Harlan Laboratories.

Sweden’s Recipharm looks to engage customers earlier with $1.8m acquisition

23-Jun-2015 - Recipharm has completed the acquisition of Uppsala, Sweden-based CRO OnTarget Chemistry for about $1.8m (SEK 15.1m). 

Scientists create 3D multiple myeloma model to aid preclinical development efforts

22-Jun-2015 - Scientists have developed a new way of visualizing multiple myelomas in 3D by replicating tumours in hens’ eggs in a approach they say will aid drugmakers.

Glowing mice with working immune systems make for better cancer models say scientists

19-Jun-2015 - Mice engineered to recognise light-emitting markers as self will let cancer drug developers to track tumor growth in animals with functioning immune systems say US researchers.

Medivir had no concerns about selecting GVK for discovery services; Assessing cathepsin S options

18-Jun-2015 - Swedish drugmaker Medivir has consolidated its drug discovery efforts though a deal with Indian CRO GVK Bio.

Mammary glands in a dish: Scientists recreate tissues for better models; spin out CRO planned

15-Jun-2015 - Researchers say a hydrogel that prompts cells to form tissue-like structures in vitro could be used to make more accurate preclinical disease models.

US spends billions on irreproducible preclinical studies say researchers

12-Jun-2015 - The US spends billions on preclinical research that cannot be replicated due to errors in design, problems with lab protocols and mistakes during data analysis according to new research.

FDA offers guidance for running early-phase trials for gene, cell therapies

12-Jun-2015 - As the hype continues to hover around the promise of gene and cell therapies, the latest guidance from the FDA will help sponsors, CROs and investigators design early-phase clinical trials...

Organovo on track for 3D bio-printed kidney tissue model

11-Jun-2015 - Organovo is looking to bring its 3D bioprinted kidney tissues to market in September 2016 following the launch of its preclinical Human Liver system.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...